Uncovering High-Impact Savings | The HighTouchRx Approach - Prime Therapeutics
Power your success with combined pharmacy and medical data
All in one innovative product.
Integrated data reveals savings opportunities
Finding and supporting members with complex conditions helps lower costs for health plans, employers and members. HighTouchRx® applies exclusive clinical predictive modeling to your medical and pharmacy data, making it easy to quickly determine high-cost members and offer interventions. Since April 2022, HighTouchRx has saved commercial and Medicare plans over $150M.
Pharmacy + medical data
Identify 1,000+ medical drugs and pharmacy savings opportunities.
Specialized outreach
Partner with clinical pharmacists to provide high-touch outreach.
Improved care
Promote member safety and savings opportunities.
Analytic intel + insights
HighTouchRx rules engine identified a member who recently initiated Mounjaro treatment and has continued their previously prescribed Ozempic. Member has continued to have both medications filled for the past two months.Outreach
The HighTouchRx pharmacist reached out directly to the member’s provider and encouraged consolidation to a single GLP-1 therapy to reduce costs and prevent adverse events.Optimization
The member discontinued Ozempic treatment and continued Mounjaro monotherapy for their diabetes treatment.Outcome
Recognized for cost containment
Footnotes
*All brand names are property of their respective owners.
Integrated data reveals savings opportunities
Finding and supporting members with complex conditions helps lower costs for health plans, employers and members. HighTouchRx® applies exclusive clinical predictive modeling to your medical and pharmacy data, making it easy to quickly determine high-cost members and offer interventions. And the best part? HighTouchRx is available to all lines of business.
Pharmacy + medical data
Identify 1,000+ medical drugs and pharmacy savings opportunities.
Specialized outreach
Partner with clinical pharmacists to provide high-touch outreach.
Improved care
Promote member safety and savings opportunities.
$150M+
Since its launch, HighTouchRx has saved commercial and Medicare plans $150M+.
$12K
In 2024, our customers saw $12K average savings per converted drug across all rules.
3:1 ROI
Customers realize a 3:1 return on investment (ROI) one year after a member has implemented a recommended therapy change.1
50 NPS
HighTouchRx has achieved a 50 Net Promoter Score (NPS).2
Real-world savings
SAVINGS PER CASE
$194,300
ROI
1,275%
Exceeding guarantees
An employer group with 7,000 lives implemented HighTouchRx. They saw savings of $194,300, with HighTouchRx providing a 1,275% ROI, exceeding our guarantee.3
SAVINGS PER CASE
$11,500
Eliminating duplicate therapies
HighTouchRx identified a member who had been using both Mounjaro and Ozempic for two months. A pharmacist reached out to the provider, who switched the member to a single GLP-1 therapy, resulting in $11,500 in savings and reducing the likelihood of adverse side effects.3
Award-winning research & support
Cystic fibrosis oversupply
See the research
Multiple sclerosis (MS) brand-to-generic switches
View the findings
Cost containment
Check out the study
Footnotes
Savings and ROI numbers shown are best results that do not guarantee future results.
All brand names are property of their respective owners.
1No impact to rebates or member cost share
2HighTouchRx client satisfaction survey 2025
3Case studies based on 2024 actual results; past results do not guarantee future results